Wang Y, Gao G, Wei X, Zhang Y, & Yu J. (2023). UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway. Dove Medical Press.
Chicago Style (17th ed.) CitationWang Y, Gao G, Wei X, Zhang Y, and Yu J. UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway. Dove Medical Press, 2023.
MLA (9th ed.) CitationWang Y, et al. UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway. Dove Medical Press, 2023.
Warning: These citations may not always be 100% accurate.